Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness

Carcinogenesis

Volumn 33, Issue 1, 2012, Pages 20-29

  Cai, Jing ^a   Tang, Huijuan ^a   Xu, Linjuan ^a   Wang, Xiaoyi ^a   Yang, Chun ^a   Ruan, Shasha ^a   Guo, Jianfeng ^a   Hu, Sha ^a   Wang, Zehua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL ISOLATION; COCULTURE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OMENTUM; OVARY CANCER; OVARY METASTASIS; PERITONEUM METASTASIS; PRIORITY JOURNAL;

EID: 84855393328     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr230     Document Type: Article

References (44)

1. Naora,H. et al. (2005) Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat. Rev. Cancer, 5, 355-366.
2. Ayantunde,A.A. et al. (2007) Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann. Oncol., 18, 945-949.
3. Sonoda,Y. (2004) Management of early ovarian cancer. Oncology (Williston Park), 18, 343-356. discussion 358, 361-2.
4. Aroeira,L.S. et al. (2007) Epithelial tomesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J. Am. Soc. Nephrol., 18, 2004-2013.
5. Kalluri,R. et al. (2006) Fibroblasts in cancer. Nat. Rev. Cancer, 6, 392-401.
6. Jimenez-Heffernan,J.A. et al. (2004) Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch., 444, 247-256.
7. Bhowmick,N.A. et al. (2004) Stromal fibroblasts in cancer initiation and progression. Nature, 432, 332-337.
8. Hwang,R.F. et al. (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res., 68, 918-926.
9. Grugan,K.D. et al. (2010) Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc. Natl. Acad. Sci. USA, 107, 11026-11031.
10. Allen,M. et al. (2011) Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J. Pathol., 223, 162-176.
11. Orimo,A. et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 121, 335-348.
12. Okawa,T. et al. (2007) The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes Dev., 21, 2788-2803.
13. Chang,H.Y. et al. (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl Acad. Sci. USA, 99, 12877-12882.
14. Zhang,Y. et al. (2011) Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Lett., 303, 47-55.
15. Wang,E. et al. (2005) Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer. Clin. Cancer Res., 11, 113-122.
16. Kaplan,R.N. et al. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438, 820-827.
17. Tojo,M. et al. (2005) The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factorbeta. Cancer Sci., 96, 791-800.
18. Witowski,J. et al. (2006) Peritoneal cell culture: fibroblasts. Perit Dial Int, 26, 292-299.
19. Beavis,M.J. et al. (1997) Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int, 51, 205-215.
20. LaRocca,P.J. et al. (1984) Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture. Cancer Res., 44, 2991-2999.
21. Jorres,A. et al. (1996) Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines. J. Am. Soc. Nephrol., 7, 2192-2201.
22. Stimpfl,M. et al. (1999) Expression of mucins and cytokeratins in ovarian cancer cell lines. Cancer Lett., 145, 133-141.
23. Livak,K.J. et al. (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
24. Kenny,H.A. et al. (2007) Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int. J. Cancer, 121, 1463-1472.
25. Rossello,A. et al. (2004) New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2). Bioorg. Med. Chem., 12, 2441-2450.
26. Daly,A.J. et al. (2008) Regulation of HGF and SDF-1 expression by oral fibroblasts-implications for invasion of oral cancer. Oral Oncol., 44, 646-651.
27. Kankuri,E. et al. (2005) Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res., 65, 9914-9922.
28. Vihinen,P. et al. (2005) Matrix metalloproteinases as therapeutic targets in cancer. Curr. Cancer Drug Targets, 5, 203-220.
29. De,W.O. et al. (2008) Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer, 123, 2229-2238.
30. Xouri,G. et al. (2010) Origin and function of tumor stroma fibroblasts. Semin. Cell Dev. Biol., 21, 40-46.
31. Bristow,R.E. et al. (1999) Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma. Cancer, 85, 658-668.
32. Chen,T. et al. (2001) Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas. Cancer Res., 61, 4679-4682.
33. Gortzak-Uzan,L. et al. (2008) A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers. J. Proteome Res., 7, 339-351.
34. Comoglio,P.M. et al. (2008) Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat. Rev. Drug Discov., 7, 504-516.
35. Matsumoto,K. et al. (2006) Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int. J. Cancer, 119, 477-483.
36. Ueoka,Y. et al. (2003) Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via ras mediated pathway. Mol. Cell Endocrinol., 202, 81-88.
37. Denys,H. et al. (2008) Differential impact of TGF-beta and EGF on fibroblast differentiation and invasion reciprocally promotes colon cancer cell invasion. Cancer Lett., 266, 263-274.
38. Skobe,M. et al. (1998) Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc. Natl Acad. Sci. USA, 95, 1050-1055.
39. Vihinen,P. et al. (2005) Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets, 5, 203-220.
40. Witz,C.A. et al. (2001) Composition of the extracellular matrix of the peritoneum. J. Soc. Gynecol. Investig., 8, 299-304.
41. Egeblad,M. et al. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2, 161-174.
42. Moss,N.M. et al. (2009) Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination. Cancer Res., 69, 7121-7129.
43. Kenny,H.A. et al. (2009) MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle, 8, 683-688.
44. Kenny,H.A. et al. (2008) The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J. Clin. Invest., 118, 1367-1379.